E. Ohman J:or Asset Management’s Charles River Laboratories CRL Stock Holding History

E. Ohman J:or Asset Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,600	Closed	-$480K	–	418
2024 Q4	$480K	Buy	2,600 +1,800	+225%	+$347K	0.01%	383
2024 Q3	$158K	Buy	+800	New	+$166K	﹤0.01%	408
2022 Q4	–	Sell	-2,200	Closed	-$433K	–	424
2022 Q3	$433K	Buy	+2,200	New	+$475K	0.02%	359
2022 Q1	–	Sell	-2,200	Closed	-$829K	–	433
2021 Q4	$829K	Hold	2,200	–	–	0.02%	341
2021 Q3	$908K	Buy	2,200 +300	+16%	+$125K	0.03%	310
2021 Q2	$703K	Buy	+1,900	New	+$634K	0.02%	357

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

E. Ohman J:or Asset Management's CRL Position: Q1 2025 in Review

E. Ohman J:or Asset Management sold out of Charles River Laboratories (CRL) in Q1 2025, closing a stake of 2,600 shares — an estimated $480K sold.

E. Ohman J:or Asset Management first reported a position in CRL in Q2 2021 and held it in 6 quarters. The position peaked at $908K in Q3 2021. 561 funds tracked by Wall St. Rank hold CRL as of Q1 2025.

E. Ohman J:or Asset Management reported no remaining Charles River Laboratories position as of Q1 2025 after selling out during the quarter.
E. Ohman J:or Asset Management sold 2,600 Charles River Laboratories shares in Q1 2025, an estimated $480K.
E. Ohman J:or Asset Management first reported a position in Charles River Laboratories in Q2 2021 and held it in 6 quarters.
E. Ohman J:or Asset Management's Charles River Laboratories position peaked at $908K in Q3 2021.
561 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2025.

Based on E. Ohman J:or Asset Management's 13F filing for Q1 2025, filed 11 Apr 2025.